Market cap
$23.9m
End-of-day close multiplied by current shares on issue.
GEN · NZX
General Capital is an NZX-listed financials / finance company company with HY23 - HY26 of published result briefings.
Snapshot
HY26, released 21 November 2025
| Metric | Value | Change |
|---|---|---|
| Revenue | $12.9m | ↑ +19.0% |
| NPAT | $1m | ↓ -37.5% |
| Operating cash flow | $2.8m | ↓ -81.6% |
| ROE % | 3.4% | ↓ -2.2pp |
| DPS | 0.3c | ↓ -39.6% |
| Payout ratio vs NPAT % | 19.2% | ↓ -77.3pp |
| PBT | $1.5m | ↓ -31.8% |
| FCF pre-lease | $2.8m | — |
| Debtor days | 3Outside range high debtor days. 3d; 3-period range 0d to 0d. Debtor days: 3.2 days, above normal range; 3-period mean 0.1 days, range 0.0 days-0.2 days. | n/m |
| Total assets | $275.8m | ↑ +47.2% |
Source: latest published briefing (HY26, released 21 November 2025). Change compares against the prior equivalent period: HY25, released 22 November 2024.
Valuation
A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.
The latest close and share count context for the market price.
Market cap
$23.9m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
10.87x
Recent market cap compared with trailing earnings.
EPS
0.02
Recent filing-derived earnings per share.
PEG
Not available
Not meaningful without positive comparable earnings growth.
EV/EBITDA
Not available
Not useful for this reporting shape.
P/FCF
Not available
Not available for this company right now.
P/B
0.8x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
4.6%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch readouts against real observations. Expand opens the chart at reading size.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.
Chat
Ask follow-up questions about General Capital's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Longitudinal view
The latest period is shown first.
| Metric | HY266 MONTHS21 November 2025 | FY2512 MONTHS26 May 2025 | HY256 MONTHS22 November 2024 | FY2412 MONTHS27 May 2024 | HY246 MONTHS28 November 2023 | FY2312 MONTHS29 May 2023 | HY236 MONTHS29 November 2022 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9m | $22.6m | $10.8m | $17.2m | $8.1m | $13.7m | $3.5m | Chart |
| Revenue growth % | 19.0% | 31.8% | 38.6%Outside range high revenue growth. 38.6%; 3-period range 4.4% to 34.6%. Revenue growth: 38.6%, above normal range; 3-period mean 19.3%, range 4.4%-34.6%. | 25.3% | 34.6% | -99.7% | 4.4%Outside range low revenue growth. 4.4%; 3-period range 19% to 38.6%. Revenue growth: 4.4%, below normal range; 3-period mean 30.7%, range 19.0%-38.6%. | Chart
|
| PBT | $1.5m | $3.9m | $2.2m | $3.6m | $0m | $3.3m | $1.5m | Chart |
| PBT growth % | -31.8% | 8.3% | -99.9% | -99.9% | -100.0% | n/m | — | Chart |
| NPAT | $1m | $2.8m | $1.6m | $2.6m | $0m | $2.3m | — | Chart |
| NPAT growth % | -37.5% | 7.7% | 33.0% | 15.1% | — | 73.7% | — | Chart |
| Operating cash flow | $2.8m | $41.4m | $15.3m | $4.2m | $9.9m | -$3.4m | $2.6m | Chart |
| FCF pre-lease | $2.8m | — | — | $4m | $9.9m | -$3.5m | $2.6m | Chart |
| FCF post-lease | — | — | — | — | — | — | $2.6m | — |
| DPS | 0.3c | 0.4c | 0.6c | — | — | — | — | Chart |
| Payout ratio vs NPAT % | 19.2% | 31.7% | 96.5% | — | — | — | — | Chart |
| Annual payout ratio vs EPS % | — | 31.7% | — | — | — | — | — | — |
| ROE % | 3.4% | 9.6% | 5.6% | 9.8% | 0.0% | 9.3% | — | Chart |
| Net debt | — | $148.7m | — | — | — | — | — | — |
| Debtor days | 3Outside range high debtor days. 3d; 3-period range 0d to 0d. Debtor days: 3.2 days, above normal range; 3-period mean 0.1 days, range 0.0 days-0.2 days. | 0 | 0 | — | 0 | 1 | 0Outside range low debtor days. 0d; 3-period range 0d to 3d. Debtor days: 0.0 days, below normal range; 3-period mean 1.1 days, range 0.0 days-3.2 days. | Chart
|
| Total assets | $275.8m | $218.2m | $187.4m | $163.3m | $141.5m | $136.1m | $126.3m | Chart |
Reference: annolyse.ai/companies/gen
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Statutory profit after tax.
Cash generated from operations.
Operating cash flow less capex before leases.
Free cash flow after lease payments where available.
Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.
Return on equity.
Borrowings less cash; negative values indicate net cash.
Dividend per share declared for the period.
Dividend payout against statutory NPAT.
Receivables days where the working-capital inputs are source-backed.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisFY25Result releasedAnnolyse analysis published
From Assets up 33.6% on funded growth, but ROE direction weakened
No forward targets, loan-book guidance, NIM disclosure or forward-work book is provided in the supplied materials. The HY25 half delivered 47.9% of full-year revenue but 56% of full-year NPAT, which implies a softer second-half earnings shape: roughly $1.2m of implied 2H NPAT against $1.6m in HY25, despite revenue lifting from $10.8m to $11.8m. This is consistent with acquisition-related transaction or integration costs absorbing margin in the back half, but the release does not isolate the driver.
Investors have no disclosed benchmark to test FY25 against. The release does not provide loan-book size, arrears rate, NIM, or provision coverage, all of which are needed to judge whether the larger balance sheet is translating into durable, risk-adjusted earnings.
Open questions
This briefing cannot assess whether the expanded loan book is being grown at adequate risk-adjusted returns, because net interest margin, arrears and impairment data are not disclosed in the supplied materials.
Archive
Every published Annolyse briefing for this company appears here in reverse chronological order.
HY26 · Released 21 November 2025
Around NZ$0.6m of exceptional first-half costs pushed ROE to 3.4% from 5.5% even as total assets grew 47.2% to NZ$275.8m.
FY25 · Released 26 May 2025
Balance-sheet expansion outpaced earnings, and an in-year acquisition broadens segment mix and limits clean year-on-year comparison.
HY25 · Released 22 November 2024
Operating cash of NZ$15.3m easily funds the inaugural distribution, but revenue growth has slowed sharply from the company's recent baseline.
FY24 · Released 27 May 2024
A lower tax rate and non-recurring prior-year items flattered headline growth while the dominant Finance segment's result declined.
HY24 · Released 28 November 2023
PBT grew just 1.6% and NPAT growth of 15.8% relied on a lower tax charge as the dominant Finance segment's profitability contracted.
FY23 · Released 29 May 2023
Equity grew 79.2% versus 68.4% NPAT growth, signalling capital raised to fund the loan book has yet to lift per-dollar returns.
HY23 · Released 29 November 2022
Operating leverage from a fast-scaling loan book quintupled PBT in a still-small finance company increasingly funded by term deposits.
Get the next General Capital result briefing and five-year history updates by email.